Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2020-06-25 | 2020-09-25 | 118942 |
TEVA-TOPILENE | 0.05% | OINTMENT | Resolved | 2020-06-25 | 2020-10-01 | 118948 |
TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2020-07-09 | 2020-10-30 | 119886 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-08-20 | 2020-12-17 | 122693 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2020-08-27 | 2020-09-25 | 123084 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2020-09-11 | 2020-10-01 | 124107 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-09-17 | 2020-12-17 | 124471 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-11-19 | 2021-01-21 | 128609 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2021-01-07 | 2021-02-18 | 131060 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-01-07 | 2021-02-05 | 131066 |
TEVA-TOPILENE | 0.05% | LOTION | Resolved | 2021-03-11 | 2023-04-28 | 135552 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2021-06-24 | 2022-02-05 | 141457 |
TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2021-07-08 | 2021-09-02 | 142186 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-07-22 | 2021-09-30 | 142902 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2021-07-29 | 2022-02-05 | 143239 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2021-08-27 | 2021-11-18 | 144707 |
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2021-08-27 | 2021-09-16 | 144721 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2021-10-21 | 2021-11-18 | 147696 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-01-20 | 2022-03-24 | 153147 |
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2022-01-20 | 2022-03-09 | 153150 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |